Publication:
Antibody response to hepatitis B vaccination in isolated anti-Hbc IgG positive cases

dc.contributor.authorKazak, Esra
dc.contributor.authorYılmaz, Emel
dc.contributor.authorMıstık, Reşit
dc.contributor.authorAkalın, Halis
dc.contributor.authorAkgöz, Semra
dc.contributor.authorGöral, Güher
dc.contributor.buuauthorKAZAK, ESRA
dc.contributor.buuauthorYILMAZ, EMEL
dc.contributor.buuauthorMıstık, Reşit
dc.contributor.buuauthorAKALIN, EMİN HALİS
dc.contributor.buuauthorGöral, Güher
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı.
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Mikrobiyoloji Anabilim Dalı.
dc.contributor.orcid0000-0001-7530-1279
dc.contributor.researcheridAAU-8952-2020
dc.contributor.researcheridAAG-8459-2021
dc.contributor.researcheridHTL-9425-2023
dc.contributor.researcheridDFY-3761-2022
dc.contributor.researcheridJGX-8396-2023
dc.date.accessioned2024-09-13T13:18:08Z
dc.date.available2024-09-13T13:18:08Z
dc.date.issued2012-08-01
dc.description.abstractObjective: We aimed to investigate the antibody response secondary to 1 dose of hepatitis B vaccine and factors affecting this response in isolated cases of anti-HBc IgG positive cases.Materials and Methods: Fortyone people who were positive for isolated anti-HBc and negative for other markers of hepatitis B were recruited in the study. The level of anti-HBs was measured at the 10th and 30th day after the administration of hepatitis B vaccine to these 41 people. HBV-DNA was searched with PCR in people who did not developed a secondary antibody response to one dose of vaccination at Day 10 and 30.Results: Anti-HBs was found to be at protective levels (>= 10 IU/mL) in 27 (65.8 %) out of 41 people included in the study. The antibody response developed in 27 people with one dose of vaccination was thought to be a secondary response, and the 14 people who did not form anti-HBs and were found to be negative for HBVDNA by PCR were thought to have false anti-HBc positivity and be inactive HBs Ag carriers (HBs Ag falling below the measurable level in time and presence of antiHBe or preS, S, precor, cor mutant strain infection). There was a highly significant correlation between antibody levels at Day 10 and Day 30 (p< 0.001). In addition, when the antibody levels of people who developed secondary response at Day 10 were investigated, antibody levels of non-smokers were found to be (0-1000 IU/mL; 194.3 +/- 327.2 IU/mL) significantly higher compared to smokers (0-70 IU/mL; 12 +/- 21.8 IU/mL) (p= 0.015). No statistically significant difference was determined between the antibody responses at Day 10 and Day 30 of people with a history of diabetes mellitus (DM), malignity, chronic diseases, alcohol consumption, previous HBsAg positivity and HBV-DNA positivity, anti-HCV positivity, and hepatitis B carriers in the family (p> 0.05).Conclusion: An anamnestic response is suggested in people who give anti-HBs response to one dose of hepatitis B vaccine. However, a false anti-HBc IgG positivity or undetectable levels of HBs Ag should be considered in people who do not give antibody response. According to our results smoking affects the level of antibody response negatively. But we need further studies involving more people.
dc.identifier.doi10.4274/Vhd.76486
dc.identifier.endpage75
dc.identifier.issn1307-9441
dc.identifier.issue2
dc.identifier.startpage71
dc.identifier.urihttps://doi.org/10.4274/Vhd.76486
dc.identifier.urihttps://viralhepatitisjournal.org/articles/doi/Vhd.76486
dc.identifier.urihttps://hdl.handle.net/11452/44738
dc.identifier.volume18
dc.identifier.wos000217194500008
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherGalenos Yayıncılık
dc.relation.journalViral Hepatit Dergisi-Viral Hepatitis Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHepatitis b
dc.subjectVaccine
dc.subjectAntibody responsei
dc.subjectGeneral & internal medicine
dc.titleAntibody response to hepatitis B vaccination in isolated anti-Hbc IgG positive cases
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication44aa832e-512b-446e-b095-bd59406744bd
relation.isAuthorOfPublication149687a4-4cd9-46c4-8b3a-8cbdec8ac7e9
relation.isAuthorOfPublication4fb46529-3295-4383-97b1-7c494ff32c24
relation.isAuthorOfPublication.latestForDiscovery44aa832e-512b-446e-b095-bd59406744bd

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Kazak_vd_2012.pdf
Size:
149.27 KB
Format:
Adobe Portable Document Format

Collections